STOCK TITAN

DBV TECHNOLOGIES SA (DBVTF) Financials

DBVTF OTC
Trailing 12 months to June 30, 2026
Revenue $4.9M +27.1% YoY
Net Income -$175.9M n/m YoY
EPS (Diluted) -$1.05 FY2025 annual
Free Cash Flow -$170.6M n/m YoY
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 16, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the DBVTF SEC filings page.

DBV TECHNOLOGIES SA (DBVTF) reported $4.9M in revenue over the twelve months to Jun 30, 2026, up 27.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI DBVTF FY2025

DBV Technologies remains a development-stage business, with research spending far exceeding revenue and financing supporting cash use.

Cash conversion remained closely tied to reported losses in FY2025: operating cash flow was -$121M against a net loss of $147M, so accounting losses were accompanied by a similar cash outflow. Free cash flow was -$122M against operating cash flow of -$121M, indicating capital expenditure was not the main cash use.

The FY2025 financing cash inflow was $276M while operating cash flow was -$121M; the balance-sheet rebuild therefore depended on funding rather than operations. Current assets of $213M exceeded current liabilities of $58M. A 3.7x current ratio indicates near-term reported obligations were backed by current resources despite ongoing operating losses.

Revenue rose to $5.6M in FY2025 from $4.2M in FY2024, but remained much smaller than FY2023. Research and development reached $117M and represented 2070.3% of revenue, showing that the business is still funding development at a scale disconnected from its reported revenue base.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

DBV TECHNOLOGIES SA does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Safe
8.88

DBV TECHNOLOGIES SA scores 8.88, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $1.4B against total liabilities of $64.9M. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
3/7

DBV TECHNOLOGIES SA passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) does not pass.

Earnings Quality No Cash Backing
N/A

DBV TECHNOLOGIES SA reported a net loss of $146.9M while operations used $121.2M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$700K
YoY-53.3%
QoQ-22.2%

DBV TECHNOLOGIES SA generated $700K in revenue in Q2 2026. This represents a decrease of 53.3% from the same quarter a year earlier. Against the prior quarter it is down 22.2%.

Net Income
-$50.4M
YoYn/m
QoQn/m

DBV TECHNOLOGIES SA reported a net loss of $50.4M in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)
-$0.12
QoQn/m

DBV TECHNOLOGIES SA earned -$0.12 per diluted share (EPS) in Q2 2026. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow
-$53.0M
YoYn/m
QoQn/m
5Y CAGRn/m

DBV TECHNOLOGIES SA recorded an outflow of $53.0M in free cash flow in Q2 2026, representing a cash shortfall after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Debt
$174.9M
YoY+69.5%
QoQ-23.7%
5Y CAGR+6.9%

DBV TECHNOLOGIES SA held $174.9M in cash as of Q2 2026; no long-term debt figure is on record for that period.

Shares Outstanding
296M
QoQ0.0%

DBV TECHNOLOGIES SA had 296M shares outstanding in Q2 2026. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Return on Equity
-31.4%
YoY+17.2pp
QoQ-8.5pp

DBV TECHNOLOGIES SA's quarterly ROE was -31.4% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is up 17.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 8.5 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending
$31.2M
YoY-7.4%
QoQ-6.6%

DBV TECHNOLOGIES SA invested $31.2M in research and development in Q2 2026. This represents a decrease of 7.4% from the same quarter a year earlier. Against the prior quarter it is down 6.6%.

Capital Expenditures
$400K
YoYn/m
QoQ0.0%
5Y CAGR+18.5%

DBV TECHNOLOGIES SA invested $400K in capex in Q2 2026, funding long-term assets and infrastructure. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. It is unchanged from the prior quarter.

Share Buybacks

Not reported for Q2 2026.

DBVTF Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DBVTF quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$700K-53.3%$900K+12.5%$562K+10.0%$2.8M+158.8%$1.5M+29.2%$800K-43.1%$511K-94.2%$1.1M-54.8%
R&D Expenses$31.2M-7.4%$33.4M+55.3%$32.9M+73.9%$28.6M+20.9%$33.7M+32.8%$21.5M+0.5%$18.9M+48.0%$23.7M+71.5%
SG&A Expenses$20.1M+125.8%$15.3M+159.3%$12.8M+133.6%$8.4M+9.0%$8.9M-7.6%$5.9M-31.1%$5.5M-31.8%$7.7M+13.0%
Operating Income-$50.6Mn/m-$47.9Mn/m-$45.1Mn/m-$34.3Mn/m-$41.1Mn/m-$26.6Mn/m-$23.9Mn/m-$30.3Mn/m
Income Tax$200K+100.0%$200Kn/m$391K+5485.7%$0n/m$100Kn/m$0-100.0%$7Kn/m$0n/m
Net Income-$50.4Mn/m-$47.6Mn/m-$44.8Mn/m-$33.2Mn/m-$41.9Mn/m-$27.1Mn/m-$23.0M-117.1%-$30.4Mn/m
EPS (Basic)-$0.12-$0.11-$0.23-$0.24n/m-$0.31n/m-$0.26n/m-$0.22n/m-$0.32n/m
EPS (Diluted)-$0.12-$0.11-$0.23-$0.24n/m-$0.31n/m-$0.26n/m-$0.22n/m-$0.32n/m
Diluted Shares (Avg)434M428MN/A137M+42.2%134M+39.8%103M+6.7%N/A96M+0.1%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, EBITDA, Interest Expense.

DBVTF Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DBVTF quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$223.2M+55.6%$266.4M+426.9%$233.7M+255.9%$110.5M+18.7%$143.4M+25.6%$50.6M-65.3%$65.7M-64.1%$93.1M-51.0%
Current Assets$201.9M+66.5%$246.7M+746.4%$212.9M+379.6%$88.9M+29.3%$121.2M+34.8%$29.1M-75.6%$44.4M-72.1%$68.8M-59.4%
Cash & Equivalents$174.9M+69.5%$229.2M+1668.2%$194.2M+498.3%$69.8M+50.4%$103.2M+55.9%$13.0M-87.2%$32.5M-77.0%$46.4M-68.9%
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Total Liabilities$62.8M+9.8%$58.4M+22.5%$64.9M+69.6%$57.6M+47.7%$57.2M+63.0%$47.7M+39.3%$38.3M-10.6%$39.0M-14.8%
Current Liabilities$54.3M+9.9%$51.8M+28.3%$58.0M+86.3%$49.5M+60.1%$49.4M+80.5%$40.4M+52.5%$31.1M-16.6%$30.9M-1.7%
Non-Current Liabilities$8.5M+9.3%$6.7M-8.3%$6.9M-3.3%$8.2M+0.6%$7.8M+0.9%$7.3M-5.8%$7.1M+30.7%$8.1M-43.5%
Total Equity$160.4M+86.1%$207.9M+7069.0%$168.8M+516.1%$52.9M-2.2%$86.2M+9.0%$2.9M-97.4%$27.4M-80.5%$54.0M-62.5%
Retained Earnings-$270.3Mn/m-$440.7Mn/m-$393.1Mn/m-$348.3Mn/m-$315.1Mn/m-$313.5Mn/m-$286.4Mn/m-$263.3Mn/m

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.

DBVTF Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DBVTF quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow-$52.6Mn/m-$49.1Mn/m-$35.2Mn/m-$32.4Mn/m-$33.9Mn/m-$19.7Mn/m-$12.3Mn/m-$22.5Mn/m
Stock-Based Compensation$3.7M+208.3%$2.3M+35.3%N/A$516K-67.5%$1.2M-21.3%$1.7M-13.2%N/A$1.6M+17.5%
Capital Expenditures$400Kn/m$400Kn/m$373K+198.4%$159K-59.8%$0-100.0%$0-100.0%-$125K-64.5%$396K+692.0%
Free Cash Flow-$53.0Mn/m-$49.5Mn/m-$35.5Mn/m-$32.6Mn/m-$33.9Mn/m-$19.7Mn/m-$12.4Mn/m-$22.9Mn/m
Investing Cash Flow-$600Kn/m-$300Kn/m-$715K-190.2%-$254Kn/m$0-100.0%-$400Kn/m$793Kn/m-$109Kn/m
Financing Cash Flow$100K-99.9%$88.9Mn/m$159.1M+23464.4%$122K+1642.9%$117.0Mn/m$0n/m$675Kn/m$7Kn/m

Not reported in any period shown, so not listed: Depreciation & Amortization, Dividends Paid, Share Buybacks.

DBVTF Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DBVTF quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Margin-7228.6%-5322.2%-8021.2%-1235.7%-2740.0%-3325.0%-4669.5%-2829.1%
Net Margin-7200.0%-5288.9%-7968.5%-1195.5%-2793.3%-3387.5%-4503.9%-2839.7%
Return on Equity-31.4%+17.2pp-22.9%+911.6pp-26.5%+57.5pp-62.7%-6.4pp-48.6%-6.7pp-934.5%-910.0pp-84.0%-179.8pp-56.3%-44.7pp
Return on Assets-22.6%+6.6pp-17.9%+35.7pp-19.2%+15.9pp-30.0%+2.7pp-29.2%-0.2pp-53.6%-34.9pp-35.0%-108.4pp-32.7%-23.9pp
Current Ratio3.72+1.3x4.76+4.0x3.67+2.2x1.80-0.4x2.45-0.8x0.72-3.8x1.43-2.8x2.22-3.2x
Liabilities-to-Equity0.39-0.3x0.28-16.2x0.38-1.0x1.09+0.4x0.66+0.2x16.44+16.1x1.40+1.1x0.72+0.4x
Asset Turnover0.000.0x0.000.0x0.000.0x0.030.0x0.010.0x0.020.0x0.010.0x0.010.0x
FCF Margin-7571.4%-5500.0%-6324.9%-1174.0%-2260.0%-2462.5%-2422.1%-2131.8%

Not reported in any period shown, so not listed: Gross Margin, Debt-to-Equity.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Frequently Asked Questions

What is DBV TECHNOLOGIES SA's annual revenue?

DBV TECHNOLOGIES SA (DBVTF) reported $5.6M in total revenue for fiscal year 2025. This represents a 35.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is DBV TECHNOLOGIES SA's revenue growing?

DBV TECHNOLOGIES SA (DBVTF) revenue grew by 35.8% year-over-year, from $4.2M to $5.6M in fiscal year 2025.

Is DBV TECHNOLOGIES SA profitable?

No, DBV TECHNOLOGIES SA (DBVTF) reported a net loss of $175.9M over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net loss of $146.9M.

DBV TECHNOLOGIES SA (DBVTF) reported diluted earnings per share of -$1.05 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

DBV TECHNOLOGIES SA (DBVTF) had EBITDA of -$144.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

DBV TECHNOLOGIES SA (DBVTF) has a return on equity of -87.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

DBV TECHNOLOGIES SA (DBVTF) recorded an outflow of $121.7M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

DBV TECHNOLOGIES SA (DBVTF) recorded an outflow of $121.2M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

DBV TECHNOLOGIES SA (DBVTF) had $233.7M in total assets as of fiscal year 2025, including both current and long-term assets.

DBV TECHNOLOGIES SA (DBVTF) invested $532K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

DBV TECHNOLOGIES SA (DBVTF) invested $116.7M in research and development during fiscal year 2025.

DBV TECHNOLOGIES SA (DBVTF) had 296M shares outstanding as of fiscal year 2025.

DBV TECHNOLOGIES SA (DBVTF) had a current ratio of 3.67 as of fiscal year 2025, which is generally considered healthy.

DBV TECHNOLOGIES SA (DBVTF) had a liabilities-to-equity ratio of 0.38 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.

DBV TECHNOLOGIES SA (DBVTF) had a return on assets of -62.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

At the end of fiscal year 2025, DBV TECHNOLOGIES SA (DBVTF) held $194.2M in cash, cash equivalents and investments, and reported an operating cash outflow of $121.2M over that year. Dividing the one by the other, the reported balance equals about 19 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

DBV TECHNOLOGIES SA (DBVTF) has an Altman Z-Score of 8.88, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

DBV TECHNOLOGIES SA (DBVTF) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

DBV TECHNOLOGIES SA (DBVTF) reported a net loss of $146.9M while operations used $121.2M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top